Literature DB >> 11438169

Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice.

S Roy1, J H Wang, S Balasubramanian, R Charboneau, R Barke, H H Loh.   

Abstract

Mu-opioid receptor knockout mice (MORKO), were used to address two questions: (1) if morphine induced decrease in thymic weight and cell distribution is mediated by the mu-opioid receptor and (2) the role of corticosteroids in morphine mediated alteration in thymic cell distribution. Our result show that morphine mediated increase in plasma corticosterone is mediated by the mu-opioid receptor since morphine at doses as high as 25 mg/kg-body weight does not increase plasma corticosterone levels in the MORKO. In addition, we have also shown that morphine treatment results in the differentiation of CD4+CD8+ (double positive cells) to single positive CD4+ cells while dexamethasone treatment results in the deletion of CD4+CD8+ (double positive) cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438169     DOI: 10.1016/s0165-5728(01)00299-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  A role for corticosterone in impaired intestinal immunity and barrier function in a rodent model of acute alcohol intoxication and burn injury.

Authors:  Mashkoor A Choudhry; Xiaoling Li; Irshad H Chaudry
Journal:  J Neuroimmune Pharmacol       Date:  2006-12       Impact factor: 4.147

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 3.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

4.  Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids.

Authors:  Subhas Das; Jennifer Kelschenbach; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

5.  Depletion and recovery of lymphoid subsets following morphine administration.

Authors:  E Y Zhang; J Xiong; B L Parker; A Y Chen; P E Fields; X Ma; J Qiu; T M Yankee
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 6.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

Review 7.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

8.  Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice.

Authors:  Soichiro Ide; Ichiro Sora; Kazutaka Ikeda; Masabumi Minami; George R Uhl; Kumatoshi Ishihara
Journal:  Neuropharmacology       Date:  2009-07-14       Impact factor: 5.250

9.  Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model.

Authors:  Sulie L Chang; Jose A Beltran; Shilpa Swarup
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.